References
- 1. May AW, Orlando ES: Prostate Cancer A Practical Guide, China, Saunders Elsevier, 2008.
- 2. Heidenreich A, Bastian PJ, Bellmunt J: European Association of Urology Guidelines on Prostate Cancer 2013, http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf
- 3. DjavanB: Prostate Biopsies and the Vienna Nomograms, European Urology, 2006;Suppl 5 500-510.
- 4. Nelson AW, Harvey RC, Parker RA, Department of Urology, Addenbrooke’s Hospital, Cambridge, United Kingdom: Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057480
- 5. Ukimura O, Coleman J A, Emberton M: Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care. European urology 2012;63:214 - 230
- 6. Robert J H, Stephen J F: 5-a reductase inhibitors and prostate cancer prevention: where do we turn now? BMC Medicine 2011;9:105
- 7. Werahera PN, Sullivan K, La Rosa FG, at all: Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume. International journal of clinical and experimental pathology. 2012;5:892-899.
- 8. Van Renterghem K, Van Koeveringe G, Achten R, at all: A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies. International urology and nephrology. 2010;42:29-38
- 9. Schoenfield L, Jones JS, Zippe CD, at all: The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU international. 2007;99:770-774
- 10. Fadi Brimo, Robin T. Vollmer, at all: Outcome for Repeated Biopsy of the Prostate, Am J Clin Pathol 2007;128:648-652